Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-001429
Filing Date
2025-01-06
Accepted
2025-01-06 18:07:58
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm252003-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm252003-4_4seq1.xml 4 5963
  Complete submission text file 0001104659-25-001429.txt   7684
Mailing Address C/O PROTAGONIST THERAPEUTICS, INC. 521 COTTONWOOD DRIVE, SUITE 100 MILPITAS CA 95035
Business Address
PATEL DINESH V PH D (Reporting) CIK: 0001120477 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 25512739

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)